The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation

Nuclear localization of the transcriptional activator NF-κB (nuclear factor κB) is controlled in mammalian cells by three isoforms of NF-κB inhibitor protein: IκBα, -β, and -ɛ. Based on simplifying reductions of the IκB–NF-κB signaling module in knockout cell lines, we present a computational model that describes the temporal control of NF-κB activation by the coordinated degradation and synthesis of IκB proteins. The model demonstrates that IκBα is responsible for strong negative feedback that allows for a fast turn-off of the NF-κB response, whereas IκBβ and -ɛ function to reduce the system's oscillatory potential and stabilize NF-κB responses during longer stimulations. Bimodal signal-processing characteristics with respect to stimulus duration are revealed by the model and are shown to generate specificity in gene expression.

[1]  Elmer S. West.  From the U. S. A. , 1965 .

[2]  B. Bainbridge,et al.  Genetics , 1981, Experientia.

[3]  K. Hagino-Yamagishi,et al.  [Oncogene]. , 2019, Gan to kagaku ryoho. Cancer & chemotherapy.

[4]  G. Chapman.  Reproductive versatility in the grasses. , 1991 .

[5]  AC Tose.  Cell , 1993, Cell.

[6]  G P Nolan,et al.  The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms. , 1993, Genes & development.

[7]  D. Baltimore,et al.  Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice. , 1995, Genes & development.

[8]  A. Mccarthy.  Development , 1996, Current Opinion in Neurobiology.

[9]  C. Stewart,et al.  IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice , 1996, Molecular and cellular biology.

[10]  A. Israël,et al.  I kappa B epsilon, a novel member of the IκB family, controls RelA and cRel NF‐κB activity , 1997 .

[11]  R. Bravo,et al.  Functional Redundancy of the Nuclear Factor κB Inhibitors IκBα and IκBβ , 1998, The Journal of experimental medicine.

[12]  M J May,et al.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.

[13]  A. Fields,et al.  Interleukin-1-induced Nuclear Factor-κB-IκBα Autoregulatory Feedback Loop in Hepatocytes , 1999, The Journal of Biological Chemistry.

[14]  A. Fontana,et al.  Role of IκBα and IκBβ in the biphasic nuclear translocation of NF‐κB in TNFα‐stimulated astrocytes and in neuroblastoma cells , 1999 .

[15]  Yukio Nakamura,et al.  Genetic approaches in mice to understand Rel/NF-κB and IκB function: transgenics and knockouts , 1999, Oncogene.

[16]  A. Israël,et al.  IκBε-Deficient Mice: Reduction of One T Cell Precursor Subspecies and Enhanced Ig Isotype Switching and Cytokine Synthesis , 1999, The Journal of Immunology.

[17]  H. Pahl.  Activators and target genes of Rel/NF-κB transcription factors , 1999, Oncogene.

[18]  U Alon,et al.  Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Eva E. Qwarnstrom,et al.  Dynamic Shuttling of Nuclear Factor κB between the Nucleus and Cytoplasm as a Consequence of Inhibitor Dissociation* , 2000, The Journal of Biological Chemistry.

[20]  P. Tak,et al.  NF-κB: a key role in inflammatory diseases , 2001 .

[21]  W. Tam,et al.  IκB Family Members Function by Different Mechanisms* , 2001, The Journal of Biological Chemistry.

[22]  R. Gaynor,et al.  Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. , 2001, The Journal of clinical investigation.

[23]  S. Saccani,et al.  Two Waves of Nuclear Factor κb Recruitment to Target Promoters , 2001, The Journal of experimental medicine.